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Introduction
Intermolecular end-to-middle domain pairing between a thrombin-exposed 'A' polymerization site in the central 'E' domain of fibrin, and a constitutive complementary 'a' site in each outer 'D' domain ('D:E'), is necessary but not alone sufficient for normal fibrin assembly, as judged from previous studies of a congenital dysfibrinogen, Tokyo II (y275 arg-+cys), which showed defective fibrin clot assembly and a normal D:E interaction (Matsuda, M., M. Baba, K. Morimoto, and C. Nakamikawa, 1983. J. Clin. Invest. 72:1034-1041). In addition to the 'a' polymerization site, two other constitutive intermolecular association sites on fibrinogen D domains have been defined: between y chain regions containing the carboxy-terminal factor XMa crosslinking site ('yxL:yxLj); and between sites located at the outer ends of each molecule ('D:D') (Mosesson, M. W., K. R. Siebenlist, J. F. Hainfeld, and J. S. Wall, manuscript submitted for publication). We evaluated the function of these sites in Tokyo H fibrinogen, and confirmed that there was a normal fibrin D:E interaction, as determined from a normal fibrin crosslinking rate in the presence of factor XHIa. We also found a normal yxL:yxL interaction, as assessed by a normal fibrinogen crosslinking rate. Judging from electron microscopic images, factor XIa-crosslinked Tokyo II fibrinogen failed to form elongated double-stranded fibrils like normal fibrinogen. Instead, it formed aggregated disordered collections of molecules, with occasional short fibrillar segments. In addition, Tokyo II fibrin formed an abnormal, extensively branched clot network containing many tapered terminating fibers. These findings indicate that the Tokyo II Fibrin polymerization begins after cleavage and release of two amino-terminal A fibrinopeptides from the central 'E' domain of fibrinogen molecules, exposing each of the 'A' polymerization sites they mask in precursor fibrinogen molecules ( 1-5 ). Each exposed 'A' site then combines noncovalently with a constitutive complementary 'a' site in the outer 'D' domain of a neighboring fibrin molecule, a necessary interaction ('D:E') for producing the half-staggered, end-to-middle domain pairing that results in twisting (6-10), double-stranded fibrils (6) (7) (8) (9) (10) (11) (12) (13) (14) (Fig.  1) . Although it is known from many previous studies (1-5, 13, 14 inter alia) that the D:E interaction is required for normal fibrin assembly, it is not clear whether this reaction alone is sufficient for this process to occur.
Fibrinogen Tokyo II is an hereditary heterozygotic dysfibrinogenemia associated with defective fibrin assembly (15) , and characterized by replacement of y275 arginine by cysteine in affected molecular D domains ( 16) . The same y chain substitution and type of abnormal fibrin polymerization have been reported in five other families: fibrinogens Osaka II, Tochigi, Morioka, Baltimore IV and Milano V ('16, 17) . Six other y275 mutations (arg-+his) include fibrinogens Haifa, Bergamo II, Essen, Perugia, Saga, and Osaka III, which also display abnormal fibrin assembly (16) .
Defective fibrin assembly of fibrinogen Tokyo II is featured by a markedly prolonged thrombin clotting time that is partially corrected by addition of calcium (15) . Tokyo II fibrinogen bound normally to insolubilized normal fibrin, indicating that the D:E interaction was normal. D dimers derived by plasmin digestion of crosslinked fibrin were also normal by SDS-PAGE, but when they were compared functionally with normal, Tokyo II D dimers showed defective binding to fibrin fragment E. This abnormal behavior indicated that there was a unique region in the Tokyo II D domain, distinct from the 'a' polymerization site, that accounted for abnormal fibrin assembly. The defective site was tentatively ascribed to a so-called 'lateral association site' ('bb') (18) , that interacts with the E domain 'B' site that becomes exposed after cleavage of fibrinopeptide B (4, 18 Recognition of the existence of these two self-association sites raised the possibility that the functional abnormality in Tokyo II fibrinogen might be related to a defect in one of them, D:D, rather than to the so-called 'bb' site interaction. In this report, we addressed that possibility by investigating the structure of Tokyo II fibrin and factor XIIIa-crosslinked fibrinogen polymers in the context of the relevant functional features of each of the D domain self-association sites.
Methods
Crosslinked fibrinogen and fibrin. Normal fibrinogen fraction 1-2 was prepared as previously described (22) . Tokyo II fibrinogen was prepared as described by Matsuda et al. (15) . Plasma factor XII (23) at a concentration of 500 Loewy U/ml in 0.1 M NaCI, 20 Hirudin-treated factor XIIIa had no measureable residual thrombin activity as assessed by its failure to release detectable FPA from fibrinogen (24) at a final factor XIIIa concentration of 100 U/ml over a 24 hour incubation period, or to cleave the fibrinogen Aa chain as assessed by SDS-PAGE of reduced fibrinogen specimens.'
For SDS-PAGE analyses of fibrinogen or fibrin crosslinking, factor XIIIa (50 to 100 U/ml, final concentration) containing hirudin-inactivated thrombin or active thrombin (not hirudin treated), respectively, was added to a fibrinogen solution (1 mg/ml final) in 0.1 M NaCl, 20 mM Hepes, pH 7 buffer containing 10 
Results
Tokyo II fibrin. The Tokyo II fibrin clot formed an extensively branched fiber network that had a lower fiber density than normal fibrin, and was featured by the presence of numerous tapered terminating fibers (Fig. 2 A) . Including calcium ions in the Tokyo II clotting mixture resulted in somewhat greater fiber density and thinner fibers, but the extensive branching and tapering terminal fibers remained (Fig. 2 B) . Morphological differences in normal fibrin matrix structure in the presence or absence of calcium ions were minimal. The greater widths of Tokyo II fibers in buffer compared with normal fibrin or Tokyo II fibrin formed in the presence of calcium, is probably related to the slow kinetics of Tokyo II fibrin assembly in buffer, since slowly polymerizing clots develop thicker fiber bundles than more rapidly formed clots (8, (26) (27) (28) (Fig. 3 A) and by densitometric gel scanning (Fig.  3 B) . Complete y chain crosslinking was observed for both normal and Tokyo II fibrin at the earliest time point (5 min), suggesting that their crosslinking rates were the same. When the fibrin crosslinking experiment was repeated under the same conditions with earlier sampling, complete y chain crosslinking occurred at the earliest sampling time (1 min; data not shown), indicating that fibrin -y chain crosslinking is at least 40-fold faster than that of each respective fibrinogen. These observa- tions are consistent with our recent findings on the differences between the crosslinking rates of normal fibrinogen and fibrin, 1 and confirms the conclusion that the fibrin D:E association accounts for the higher crosslinking rate of fibrin over fibrinogen (29, 30 ). The fact that Tokyo H fibrinogen manifests the same degree of accelerated crosslinking as normal fibrin, provides confirmation for the previous finding based on fibrin affinity chromatography experiments that the D:E interaction in Tokyo H is normal (15) .
Crosslinked Tokyo Ilfibrinogen polymer structure. Normal fibrinogen that had been crosslinked in the presence of factor XIlla formed elongated double-stranded fibrils (Fig. 4) , whereas Tokyo II fibrinogen did not (Fig. 5) . The constituent fibrinogen molecules within each normal fibrinogen fibril strand were aligned end-to-end to form the intermolecular DD complexes that resulted from the 'D:D' association reaction, and the fibril strands became aligned in parallel because of the y chain crosslinks that bridge the fibril strands. The half-staggered arrangement of molecules constituting the fibrinogen fibrils causes them to have 22.5 nm periodicity. ' Crosslinked Tokyo II fibrinogen, although it had become crosslinked at the same rate and to the same extent as normal fibrinogen (Fig. 3) , formed polymeric structures that were not as well ordered as normal crosslinked fibrinogen fibrils (Fig.  5 ). Most commonly, Tokyo H fibrinogen formed aggregated collections of crosslinked molecules, with occasional short double-stranded fibrillar segments with -22.5 nm periodicity (Fig. 5 A, C, and F) . These 'normal' fibril segments probably reflect a subpopulation of Tokyo H fibrinogen molecules having two functionally normal D domains (i.e., "normal homodimers" ), that are present in the heterozygous fibrinogen population (Fig. 6) (Table I ). The existence of a D:D self-association site has also been suggested from other studies on fibrinogen or fibrin assembly (19) (20) (21) .
Previous studies had indicated that the fibrin D:E interaction was normal in Tokyo II fibrin, and that factor XlIIa-mediated crosslinking of Tokyo II fibrin was also normal (15). Our present studies extend those observations to show that the rate as well as the extent of crosslinking of fibrin Tokyo H is the same as that of its normal counterpart, strongly reinforcing the notion of a normal D:E interaction. The fact that the crosslinking rate of Tokyo H fibrinogen is also the same as its normal counterpart indicates that xL:yxL self-association sites are normal. Despite this, assembly of crosslinked Tokyo II fibrinogen is grossly abnormal, thus pointing directly to a defective D:D self-association site interaction. This heterozygous deficiency, which is caused by y275 arg--cys mutations involving half the fibrinogen D domains, results in abnormal end-to-end associations during factor XIIIa-catalyzed fibrinogen polymer assembly and also, as assessed by morphological appearances, during fibrin assembly. Thus, these studies on Tokyo H fibrin and crosslinked fibrinogen polymer structure, advance our understanding of the specific self-association sites that participate in the fibrin assembly process. They indicate that the D:E interaction is necessary but not alone sufficient for fibril assembly, and that the D:D interaction is also required.
Our findings also indicate that the D:D interaction is an important determinant of the ultimate network structure of the fibrin clot. The Tokyo II fibrin network is more highly branched than its normal counterpart (Fig. 2) , an observation that is very similar to those we have made on fibrinogens having a mutation at the same site-Haifa (y275 arg--his) (31) and Morioka (y275 arg-.cys) (32) . The likely explanation for increased branching is that impairment of intermolecular D:D interactions permits fibrin molecules to extend outward from linearly propagating fibril strands more frequently, thus favoring formation of greater numbers of branch points (25) .
The abnormality in Tokyo H D dimer binding to the fibrin E domain had tentatively been attributed to a defect in a region expressed in the linearly aligned dimeric D domain ('bb') that participates in lateral fibril association ( 18) via interaction with an exposed 'B' site in the fibrin E domain. Based upon our present observations on crosslinked fibrinogen polymers, in which the fibrinogen E domain plays no obvious role in the assembly process, this surmise does not seem to be the case. Our 
